Cargando…
Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages
Immunosuppression is a significant factor in the progression of tumor invasion and metastasis. Melatonin, a well-known hormone, has certain cytotoxic and immune regulatory effects to inhibit tumor function. Exosomes are small membrane vesicles released by many kinds of cells, which contain different...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485628/ https://www.ncbi.nlm.nih.gov/pubmed/28655998 http://dx.doi.org/10.7150/ijbs.19642 |
_version_ | 1783246107372945408 |
---|---|
author | Cheng, Liang Liu, Jiatao Liu, Qingqing Liu, Yu Fan, Lulu Wang, Fang Yu, Hanqing Li, Yuhuan Bu, Lijia Li, Xiaoqiu Wei, Wei Wang, Hua Sun, Guoping |
author_facet | Cheng, Liang Liu, Jiatao Liu, Qingqing Liu, Yu Fan, Lulu Wang, Fang Yu, Hanqing Li, Yuhuan Bu, Lijia Li, Xiaoqiu Wei, Wei Wang, Hua Sun, Guoping |
author_sort | Cheng, Liang |
collection | PubMed |
description | Immunosuppression is a significant factor in the progression of tumor invasion and metastasis. Melatonin, a well-known hormone, has certain cytotoxic and immune regulatory effects to inhibit tumor function. Exosomes are small membrane vesicles released by many kinds of cells, which contain different macromolecules, such as mRNAs and microRNAs (miRNAs), and proteins that can mediate communications between cells. Tumor-derived exosomes may cause immunosuppression, however, it is unknown whether melatonin can attenuate an immunosuppressive status by altering the function of tumor-derived exosomes. In the present study, we evaluated the effects of hepatocellularcarcinoma-derived exosomes (Exo-con) and exosomes derived from hepatocellularcarcinoma cells treated with 0.1 mM melatonin (Exo-MT), on the expression of inflammatory factors and programmed death ligand 1(PD-L1) by co-culturing Exo-con and Exo-MT, respectively, with macrophages differentiated from THP-1 cells or RAW264.7 cells. Our in vitro results indicate that Exo-MT can downregulate the expression of PD-L1 on macrophages while Exo-con can upregulate the expression of PD-L1 through flow cytometry and immunofluorescence analysis. In addition, Exo-con upregulates the secretion of cytokines, such as IL-6, IL-10, IL-1β, and TNF-α in macrophages. Accordingly, Exo-MT could attenuate the high expression of these inflammatory cytokines. Furthermore, in vivo experiments confirmed the results found in vitro. PD-L1 expression and cytokine secretion were lower in the Exo-MT group compared with those in the Exo-con group. Working to identify a specific mechanism, our research shows that Exo-MT decreases STAT3 activation compared to the Exo-con group. In summary, we found exosomes from melatonin treated hepatocellularcarcinoma cells alters the immunosupression status through STAT3 pathway in macrophages. Our study may provide a new avenue to investigate the mechanisms of melatonin in regulating an immunosuppressive status. |
format | Online Article Text |
id | pubmed-5485628 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-54856282017-06-27 Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages Cheng, Liang Liu, Jiatao Liu, Qingqing Liu, Yu Fan, Lulu Wang, Fang Yu, Hanqing Li, Yuhuan Bu, Lijia Li, Xiaoqiu Wei, Wei Wang, Hua Sun, Guoping Int J Biol Sci Research Paper Immunosuppression is a significant factor in the progression of tumor invasion and metastasis. Melatonin, a well-known hormone, has certain cytotoxic and immune regulatory effects to inhibit tumor function. Exosomes are small membrane vesicles released by many kinds of cells, which contain different macromolecules, such as mRNAs and microRNAs (miRNAs), and proteins that can mediate communications between cells. Tumor-derived exosomes may cause immunosuppression, however, it is unknown whether melatonin can attenuate an immunosuppressive status by altering the function of tumor-derived exosomes. In the present study, we evaluated the effects of hepatocellularcarcinoma-derived exosomes (Exo-con) and exosomes derived from hepatocellularcarcinoma cells treated with 0.1 mM melatonin (Exo-MT), on the expression of inflammatory factors and programmed death ligand 1(PD-L1) by co-culturing Exo-con and Exo-MT, respectively, with macrophages differentiated from THP-1 cells or RAW264.7 cells. Our in vitro results indicate that Exo-MT can downregulate the expression of PD-L1 on macrophages while Exo-con can upregulate the expression of PD-L1 through flow cytometry and immunofluorescence analysis. In addition, Exo-con upregulates the secretion of cytokines, such as IL-6, IL-10, IL-1β, and TNF-α in macrophages. Accordingly, Exo-MT could attenuate the high expression of these inflammatory cytokines. Furthermore, in vivo experiments confirmed the results found in vitro. PD-L1 expression and cytokine secretion were lower in the Exo-MT group compared with those in the Exo-con group. Working to identify a specific mechanism, our research shows that Exo-MT decreases STAT3 activation compared to the Exo-con group. In summary, we found exosomes from melatonin treated hepatocellularcarcinoma cells alters the immunosupression status through STAT3 pathway in macrophages. Our study may provide a new avenue to investigate the mechanisms of melatonin in regulating an immunosuppressive status. Ivyspring International Publisher 2017-05-16 /pmc/articles/PMC5485628/ /pubmed/28655998 http://dx.doi.org/10.7150/ijbs.19642 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Cheng, Liang Liu, Jiatao Liu, Qingqing Liu, Yu Fan, Lulu Wang, Fang Yu, Hanqing Li, Yuhuan Bu, Lijia Li, Xiaoqiu Wei, Wei Wang, Hua Sun, Guoping Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages |
title | Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages |
title_full | Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages |
title_fullStr | Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages |
title_full_unstemmed | Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages |
title_short | Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages |
title_sort | exosomes from melatonin treated hepatocellularcarcinoma cells alter the immunosupression status through stat3 pathway in macrophages |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485628/ https://www.ncbi.nlm.nih.gov/pubmed/28655998 http://dx.doi.org/10.7150/ijbs.19642 |
work_keys_str_mv | AT chengliang exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages AT liujiatao exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages AT liuqingqing exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages AT liuyu exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages AT fanlulu exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages AT wangfang exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages AT yuhanqing exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages AT liyuhuan exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages AT bulijia exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages AT lixiaoqiu exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages AT weiwei exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages AT wanghua exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages AT sunguoping exosomesfrommelatonintreatedhepatocellularcarcinomacellsaltertheimmunosupressionstatusthroughstat3pathwayinmacrophages |